National Investigation in College and High School Among Adolescents on Health and Substances at the FSEF (EnCLASS-FSEF)

For the clinical component:

Describe the young people hospitalised in residential care at the FSEF, in particular through vulnerability factors and their psychosocial repercussions (school level, repetition, intensity of symptoms, irritability, nervousness, substance use (cannabis, alcohol, tobacco), social relationships, family relationships, well-being, level of health literacy, learning disorders)) and to compare them with young people from the general school population.

For the epidemiological aspect:

To study the construct validity of the EnCLASS questions aiming to characterize handicap situations in the general school population in both a population in situation of psychic handicap and of somatic handicap.

Study Overview

Detailed Description

Residential care in psychiatry in France, although recommended by the HAS and widely implemented, have been little evaluated In France, the residential care of the FSEF called "soins-études" have long been recognized as contributors to psychosocial rehabilitation. They hospitalize young people with mental and physical disabilities. They allow the continuation of hospital care associated with the resumption of schooling and the implementation of a training project integrated into the individualized care plan. Each year, around 1 500 young people are admitted to full-time hospitalization for "soins-études" in psychiatry or medicine (follow-up care and rehabilitation) within the FSEF. They benefit from comprehensive care, adapted to their needs, including care, maintenance or resumption of schooling and social reintegration in a peer group. A recent review of the literature showed that the provision of "soins-études" in psychiatry allows clinical improvement in nearly two-thirds of between more than 5 years after admissionit, and the resumption of schooling and a training project. The young people admitted at the FSEF generally have been receiving care for more than 3 years for chronic psychiatric disorders. Despite frequent school delays or periods of dropping out of school, a large majority of them had a school activity during the care.

However, it appears from this review that the characteristics of the young people received have never been compared with those of students in a traditional education course. Characterizing this population meets a need, as well as a strong institutional demand (FSEF, funders and national education).

The EnCLASS-FSEF survey will be rolled out with the national EnCLASS methodology in all the annexes of the National Education schools integrated into the 13 FSEF care-study clinics (therefore on the total population in care-studies of the FSEF educated in secondary school) - making it possible to describe and compare the patients treated in care studies with the general school population.

Study Type

Observational

Enrollment (Actual)

598

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75014
        • Godart Nathalie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

11 years to 20 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All young people hospitalized in care-study in the 13 clinics in the FSEF (i.e. around 1,500) over the period from March to June 2022.

Description

Inclusion Criteria:

  • Student cared for in college and high school studies in the 13 clinics of the FSEF,
  • From 11 years old,
  • Non-opposition of the student to his participation in the study and to the use of his data (and of their parents for minor students).

Exclusion Criteria:

  • Student opposition to participating in the study (or their parents for underage students).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
description of the study population
Time Frame: inclusion
Describe the young people taken into "soins étude" at the FSEF for a psychiatric pathology or for a somatic pathology, in particular through characteristic vulnerability factors and their psychosocial repercussions (school level, repetition, intensity of symptoms, irritability, nervousness, consumption of toxicants (cannabis, alcohol, tobacco), ease of having friends, quality of family relationships, well-being, level of health literacy, "dys" disorders)) and comparison with young people from the general school population. This description and comparison will be carried out thanks to the answers of the young people to the questionnaire of the national survey (identical questionnaire for the population of the FSEF and the national population).
inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
comparison
Time Frame: inclusion
Compare the levels of psychological symtoms the FSEF population to the general population (response of young people to specific questions on the subject in the national survey questionnaire).
inclusion
frequency
Time Frame: inclusion
Frequency of various psychiatric disorders within the FSEF population and description of psychotropic treatments received. Data will be collected both through young people's responses to specific questions aimed at the FSEF population and both from the participants' medical records.
inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Nathalie Godart, Fondation Santé des Étudiants de France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 1, 2022

Primary Completion (ACTUAL)

June 24, 2022

Study Completion (ACTUAL)

June 24, 2022

Study Registration Dates

First Submitted

January 17, 2022

First Submitted That Met QC Criteria

January 26, 2022

First Posted (ACTUAL)

February 4, 2022

Study Record Updates

Last Update Posted (ACTUAL)

July 26, 2022

Last Update Submitted That Met QC Criteria

July 22, 2022

Last Verified

December 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychiatric Disorder

Subscribe